Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Birchview Capital, LP
Form 13F · Q2 2026

Birchview Capital, LP

CIK 1618205申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$2.1亿
申報組合市值
73
持倉數量
12
Quarters on record
Top 50
持倉數量

Birchview Capital, LP——持倉

共 73 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1KLAC Kla Corp178,471+797.6%$5385万25.2%
2BMY Bristol-Myers Squibb Co297,243−2.9%$1713万8.0%
3LRCX Lam Research Corp35,000−2.8%$1517万7.1%
4NTLA Intellia Therapeutics Inc385,900−13.4%$678万3.2%
5SLDB Solid Biosciences Inc666,196+6.4%$666万3.1%
6BDSX Biodesix Inc286,804+0.0%$647万3.0%
7STOK Stoke Therapeutics Inc178,110−15.2%$583万2.7%
8OVV Ovintiv Inc107,500+0.0%$566万2.6%
9NKTR Nektar Therapeutics81,000+161.3%$565万2.6%
10CORT Corcept Therapeutics Inc57,200+21.2%$497万2.3%
11NBIX Neurocrine Biosciences Inc27,190+0.0%$458万2.1%
12PRTA Prothena Corp Plc449,019+0.0%$440万2.1%
13ACAD Acadia Pharmaceuticals Inc171,000+0.0%$433万2.0%
14PTGX Protagonist Therapeutics Inc35,018+0.1%$429万2.0%
15CMPX Compass Therapeutics Inc1.7M+14.3%$367万1.7%
16RLMD Relmada Therapeutics Inc408,100−0.3%$282万1.3%
17ALKS Alkermes Plc50,000+0.0%$262万1.2%
18HALO Halozyme Therapeutics Inc33,251+229.2%$260万1.2%
19CLDX Celldex Therapeutics Inc New69,900−0.3%$260万1.2%
20CYTK Cytokinetics Inc30,000+0.0%$256万1.2%
21OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc199,000−9.1%$249万1.2%
22VERA Vera Therapeutics Inc57,758+31.3%$248万1.2%
23UTHR United Therapeutics Corp Del4,506+0.1%$244万1.1%
24ZBIO Zenas Biopharma Inc93,601+33.7%$238万1.1%
25QURE Uniqure Nv50,697−49.7%$234万1.1%
26PACB Pacific Biosciences Calif In1.4M−10.0%$227万1.1%
27ABVX Abivax Sa17,000—$227万1.1%
28VIR Vir Biotechnology Inc220,000—$224万1.0%
29BIIB Biogen Inc9,000+80.0%$194万0.9%
30EQT Eqt Corp34,619+0.0%$184万0.9%
31BIOA Bioage Labs Inc69,000—$169万0.8%
32TVTX Travere Therapeutics Inc29,000−0.7%$165万0.8%
33QDEL Quidelortho Corp89,377+8.3%$157万0.7%
34AXSM Axsome Therapeutics Inc.6,000+0.0%$147万0.7%
35FHTX Foghorn Therapeutics Inc281,937+0.1%$138万0.6%
36BCYC Bicycle Therapeutics Plc313,616−32.4%$133万0.6%
37GPCR Structure Therapeutics Inc24,000−76.0%$129万0.6%
38XENE Xenon Pharmaceuticals Inc21,032+0.2%$127万0.6%
39NVO Novo-Nordisk A S24,000—$115万0.5%
40FCX Freeport Mcmoran Inc18,035−0.0%$113万0.5%
41IMNM Immunome Inc50,000+0.0%$106万0.5%
42PHVS Pharvaris N V29,847+0.0%$103万0.5%
43HROW Harrow Inc24,000+0.0%$102万0.5%
44ADAG Adagene Inc240,000—$101万0.5%
45DFTX Definium Therapeutics Inc20,000—$94万0.4%
46SLN Silence Therapeutics Plc71,218—$78万0.4%
47BBIO Bridgebio Pharma Inc8,741+0.6%$65万0.3%
48FDMT 4D Molecular Therapeutics In48,505—$65万0.3%
49URGN Urogen Pharma Ltd16,487—$61万0.3%
50PHAT Phathom Pharmaceuticals Inc55,000−71.8%$60万0.3%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。